Marjorie Taylor Greene · NVO
Marjorie Taylor Greene's NVO trades
- Transactions
- 3
- Buys / sells
- 3 / 0
- Disclosed range
- $17K – $80K
- Last filed
- 2025-10-20
NVO transactions reported by Marjorie Taylor Greene
| Type | Owner | ||||
|---|---|---|---|---|---|
Novo Nordisk A/S Common Stock NVO | Purchase | Self | $1,001 - $15,000 | 2025-10-20 #20033314 | |
Novo Nordisk A/S Common Stock NVO | Purchase | Self | $1,001 - $15,000 | 2025-08-29 #20030996 | |
Novo Nordisk A/S Common Stock NVO | Purchase | Self | $15,001 - $50,000 | 2025-08-20 #20030944 |
A row is a disclosure, not an execution record: the filing reports a date, a bracket, and the reported owner, but not the price, share count, or reason. Compare the trade date with the filing date to see how long the transaction stayed private.
The tracker is free
A STOCK Act row is evidence, not a model portfolio. Membership is the sourced monthly thesis around it.
Other House members who reported NVO
More tickers reported by Marjorie Taylor Greene
Marjorie Taylor Greene and NVO — questions
Did Marjorie Taylor Greene buy or sell NVO?
House Clerk filings for 2025 and 2026 show 3 purchases and 0 sales of Novo Nordisk A/S Common Stock (NVO) reported by Marjorie Taylor Greene, between 2025-08-19 and 2025-10-15. Reported owner: Self.
How much NVO did Marjorie Taylor Greene trade?
Filings disclose brackets, not exact values. Summing the low and high ends of each bracket gives $17K – $80K across 3 transactions. Yield Theory does not estimate share counts, prices, or gains from these ranges.
When was the last NVO filing by Marjorie Taylor Greene?
The most recent periodic transaction report containing a NVO row was filed on 2025-10-20. New filings appear in the House Clerk index and are picked up when the dataset is refreshed.
Yield Theory is not affiliated with any elected official or with Novo Nordisk A/S Common Stock. Rows are parsed from public House Clerk periodic transaction reports; amounts are reported brackets and filings can be amended. This page is educational and is not investment advice.
Don’t copy the filing. Read the thesis.
Marjorie Taylor Greene NVO disclosures are delayed, ranged, and often a spouse. Members get the monthly call that treats those rows as one input, then names catalysts, risks, and what would change the view. $15/month or $150/year.
$15/mo or $150/yr · cancel future renewals anytime · sources included